Company / Current Assets per Share
Amneal Pharmaceuticals, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.85
FY2025
5-year range
$9.08 / $11.51
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#72 of 210
Health Care
What the data says
At $10.85, Amneal Pharmaceuticals, Inc.'s current assets per share ranks #72 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 9 years, ranging from $9.08 in FY2023 to $771933.00 in FY2017.
Based on SEC 10-K filings.
10.85 in FY2025 with a 5-year CAGR of -2.3%.
Improved from $9.08 to $10.85 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 210 in Health CareTop 34% of 210This company $10.85 Sector average $170.65
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 3.2% year-over-year.
- Ranks #72 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2017.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.85 | +3.2% |
| FY2024 | $10.52 | +15.9% |
| FY2023 | $9.08 | -4.3% |
| FY2022 | $9.48 | -17.6% |
| FY2021 | $11.51 | -5.6% |
| FY2020 | $12.19 | +28.2% |
| FY2019 | $9.51 | -5.9% |
| FY2018 | $10.11 | -100.0% |
| FY2017 | $771933.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026